Kukje Pharma Co., Ltd.

₩3,200As of Sun 8 Nov 2026, 12:00 UTC
KRX:002720Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR 0.70%
Div yield 0.94%
ROE 5.18%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.14
PE TTM 13.31
TSR TTM (24.51%)
Mkt cap ₩67.71B
ROIC 3.35%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,076
(3.88%)
(48.62%)
Hold 8|6|12|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
55.13
52.50
58.25
58.42
21.01%
9.35%
21.62%
9.34%
Revenue₩B
6.199
6.312
6.344
6.533
10.98%
7.08%
10.23%
7.74%
Peers (US$49.92M)
Cap (US$)
PE
46.63M
2.890x
43.25M
5.361x
Capital
TTM
5Y
10Y
Leveragex
1.774
0.229
0.153
EBIT/Intx
16.85
0.074
0.088
Own earn%
(67.91)
34.32
42.08
Sh yield%
15.67
41.11
42.12
Owners
Insiders/Inst%
14.49
53.63
Short interest%
4.67
SBC / revenue%
2.20
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
13–17
$1 testx
0.3
Incr. ROIC%
5